Johnson & Johnson to Pay $700 Million to Settle Baby Powder Probe
Johnson & Johnson has tentatively agreed to pay about $700 million to settle an investigation brought by more than 40 states into the marketing of its talcum-based baby powder, a J&J executive said, the Wall Street Journal reported. The agreement in principle with attorney general offices in most U.S. states is an “important step” for the company, based in New Brunswick, N.J., as it tries to “reasonably put the matter behind us,” J&J Chief Financial Officer Joseph Wolk said yesterday. Johnson & Johnson has said in securities filings 42 states and Washington, D.C., had launched an investigation into its marketing of talc-based products. New Mexico and Mississippi have filed lawsuits against the company alleging violations of consumer-protection laws. The proposed settlement with states would only address a small portion of the litigation over the safety and marketing of J&J’s talcum powders. It doesn’t resolve the personal-injury lawsuits filed by more than 52,000 plaintiffs in various U.S. courts against J&J, alleging that use of the powders, primarily Johnson’s Baby Powder, caused cancer. J&J likely will have to spend billions more dollars to resolve the broader litigation. The company last year proposed paying at least $8.9 billion to resolve the personal-injury lawsuits in a bankruptcy plan filed by a subsidiary, but a bankruptcy judge rejected the plan. J&J is pursuing the consensual resolution of the personal-injury claims through another bankruptcy plan, and analysts have estimated the ultimate settlement cost could range from $10 billion to $15 billion.
